HK1031736A1 - Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties. - Google Patents

Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties.

Info

Publication number
HK1031736A1
HK1031736A1 HK01101671A HK01101671A HK1031736A1 HK 1031736 A1 HK1031736 A1 HK 1031736A1 HK 01101671 A HK01101671 A HK 01101671A HK 01101671 A HK01101671 A HK 01101671A HK 1031736 A1 HK1031736 A1 HK 1031736A1
Authority
HK
Hong Kong
Prior art keywords
glycolide
lactide
molecular weight
polyethylene glycol
low molecular
Prior art date
Application number
HK01101671A
Other languages
English (en)
Inventor
Ramesh Rathi
Gaylen M Zentner
Byeongmoon Jeong
Original Assignee
Macromed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/943,167 external-priority patent/US6004573A/en
Priority claimed from US09/164,865 external-priority patent/US6117949A/en
Application filed by Macromed Inc filed Critical Macromed Inc
Publication of HK1031736A1 publication Critical patent/HK1031736A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/06—Biodegradable
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • C08L2666/14—Macromolecular compounds according to C08L59/00 - C08L87/00; Derivatives thereof
    • C08L2666/18—Polyesters or polycarbonates according to C08L67/00 - C08L69/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyethers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK01101671A 1997-10-03 2001-03-07 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties. HK1031736A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/943,167 US6004573A (en) 1997-10-03 1997-10-03 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US09/164,865 US6117949A (en) 1998-10-01 1998-10-01 Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
PCT/US1998/020649 WO1999018142A1 (en) 1997-10-03 1998-10-02 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES

Publications (1)

Publication Number Publication Date
HK1031736A1 true HK1031736A1 (en) 2001-06-22

Family

ID=26860926

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101671A HK1031736A1 (en) 1997-10-03 2001-03-07 Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties.

Country Status (16)

Country Link
EP (1) EP1034207B1 (xx)
JP (3) JP4656725B2 (xx)
KR (2) KR20010030891A (xx)
CN (1) CN1195788C (xx)
AR (1) AR015175A1 (xx)
AT (1) ATE290037T1 (xx)
AU (1) AU736812B2 (xx)
BR (1) BR9815239B1 (xx)
CA (1) CA2305621C (xx)
DE (1) DE69829204T2 (xx)
ES (1) ES2239408T3 (xx)
HK (1) HK1031736A1 (xx)
IL (2) IL135415A0 (xx)
PT (1) PT1034207E (xx)
TR (1) TR200000900T2 (xx)
WO (1) WO1999018142A1 (xx)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6841617B2 (en) * 2000-09-28 2005-01-11 Battelle Memorial Institute Thermogelling biodegradable aqueous polymer solution
US7087244B2 (en) 2000-09-28 2006-08-08 Battelle Memorial Institute Thermogelling oligopeptide polymers
IL140268A0 (en) * 1998-06-30 2002-02-10 Amgen Inc Thermosensitive biodegradable hydrogels for sustained delivery of biologically active agents
AU1792601A (en) * 1999-12-07 2001-06-18 Amgen, Inc. Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
US6998137B2 (en) * 2000-04-07 2006-02-14 Macromed, Inc. Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
US7018645B1 (en) * 2000-04-27 2006-03-28 Macromed, Inc. Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
US6669959B1 (en) 2000-07-18 2003-12-30 Aeropharm Technology Incorporated Modulated release particles for lung delivery
NZ525726A (en) * 2000-11-09 2004-10-29 Astrazeneca Ab Oral pharmaceutical composition containing a block copolymer
US20030003074A1 (en) * 2001-06-14 2003-01-02 Macromed, Inc. Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
US7226616B2 (en) 2001-07-14 2007-06-05 Samyang Corporation Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
DE60231325D1 (de) * 2001-11-15 2009-04-09 Biomatera Inc Verfahren zur herstellung von gelen
TW200307011A (en) 2002-04-18 2003-12-01 Chugai Pharmaceutical Co Ltd Hyaluronic acid modifier
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
EP1556087A2 (en) 2002-10-31 2005-07-27 Pfizer Products Inc. Liquid conjugates of solid pharmaceuticals
FR2855521B1 (fr) 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
WO2005003214A1 (ja) 2003-07-07 2005-01-13 Nof Corporation 三元ブロック共重合体、その製造法及び生体内適合材料
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
WO2005067890A2 (en) 2004-01-13 2005-07-28 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
US20090023643A1 (en) * 2004-01-13 2009-01-22 Vasogenix Pharmaceuticals, Inc. Methods For Treating Acute Myocardial Infarction By Administering Calcitonin Gene Related Peptide And Compositions Containing The Same
EP1555278A1 (en) 2004-01-15 2005-07-20 Innocore Technologies B.V. Biodegradable multi-block co-polymers
JP2008517927A (ja) * 2004-10-21 2008-05-29 ユニバーシティー オブ アイオワ リサーチ ファンデーション ｉｎｓｉｔｕ制御放出薬剤送達システム
WO2007067624A2 (en) * 2005-12-06 2007-06-14 Tyco Healthcare Group Lp Bioabsorbable compounds and compositions containing them
ATE502640T1 (de) * 2006-01-26 2011-04-15 Us Gov Health & Human Serv Allosterische a3-adenosin-rezeptormodulatoren
JP5019851B2 (ja) * 2006-11-09 2012-09-05 学校法人 関西大学 温度応答性ゾル−ゲル転移を示す生分解性ポリマー及びその製造方法
JP5297632B2 (ja) 2006-11-17 2013-09-25 独立行政法人国立循環器病研究センター 血液凝固抑制材料並びにそれを用いたコーティング材料及び生体留置部材
PT3202814T (pt) 2007-02-15 2019-11-26 Tolmar Therapeutics Inc Poli-(lactido/glicolido) de libertação imediata reduzida e métodos de produção de polímeros
FR2915683B1 (fr) 2007-05-03 2009-08-07 Flamel Technologies Sa Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
CN101333295B (zh) * 2007-06-27 2011-01-05 中国科学院化学研究所 一种生物可降解高分子纳米粒子及其专用聚合物和它们的制备方法
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
FR2919188B1 (fr) * 2007-07-27 2010-02-26 Proteins & Peptides Man Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
US8642062B2 (en) * 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
JP4824710B2 (ja) * 2008-02-08 2011-11-30 国立清華大学 グラフト共重合体およびブロック共重合体の多機能混合ミセルならびにその製造方法
US8916188B2 (en) 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
WO2010068432A1 (en) * 2008-11-25 2010-06-17 Ecole Polytechnique Federale De Lausanne (Epfl) Block copolymers and uses thereof
JP5643824B2 (ja) * 2009-09-18 2014-12-17 プロセリクス メディスンズ ディベロプメント リミテッド 放出特性が改善されたｂａｂブロックポリマー
EP2382966A1 (en) * 2010-03-12 2011-11-02 DSM IP Assets B.V. Micelle compositions and process for the preparation thereof
AU2011230601B2 (en) * 2010-03-26 2015-04-02 Evonik Corporation Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers
CN102058909A (zh) * 2011-01-18 2011-05-18 复旦大学 聚乙二醇－共聚酯嵌段共聚物防粘连材料及其制备方法与应用
CN102181048B (zh) * 2011-03-11 2015-02-25 上海谊众生物技术有限公司 一种生物医用聚醚/聚酯嵌段共聚物的制备方法
CN102218027B (zh) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 一种包载难溶性抗肿瘤药物的聚合物胶束冻干制剂
EP2596802A1 (en) 2011-11-23 2013-05-29 PLS-Design GmbH Pharmaceutical composition for treatment of allergic reactions
WO2013118605A1 (ja) * 2012-02-08 2013-08-15 東レ株式会社 刺激応答性材料およびそれを用いた医療材料
EP2674167A1 (en) 2012-06-14 2013-12-18 PLS-Design GmbH Controlled activation of complement components for use as endogenous adjuvant
EP2674168A1 (en) 2012-06-14 2013-12-18 PLS-Design GmbH Modulation of effector T cell responses by local depletion of complement component C3
JP6119608B2 (ja) * 2012-09-24 2017-04-26 東レ株式会社 ブロック共重合体の製造方法
CN103772686B (zh) 2012-10-26 2015-01-07 苏州雷纳药物研发有限公司 一种两亲性嵌段共聚物及其制备方法、以及该共聚物与抗肿瘤药物形成的胶束载药系统
EP2746396A1 (en) 2012-12-20 2014-06-25 PLS-Design GmbH Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
CN103611196B (zh) * 2013-04-17 2015-09-16 苏州工业园区汉德医院投资管理有限公司 一种pela/bmp-2微球及其制备方法
JP6176998B2 (ja) * 2013-05-13 2017-08-09 学校法人 関西大学 温度応答性生分解性高分子組成物及びその製造方法
CN104689380A (zh) * 2013-12-10 2015-06-10 复旦大学 一种由物理交联水凝胶构成的黏膜下注射材料及其应用
CN103819905B (zh) * 2014-03-07 2016-01-20 山东理工大学 一种用聚三亚甲基碳酸酯与聚乙烯吡咯烷酮对聚肽膜亲水性进行改进的方法
EP2918262B1 (en) 2014-03-10 2023-08-09 PLS-Design GmbH Induction of antigen-specific tolerance by peripheral phagocytosis
CN104693431A (zh) * 2014-12-01 2015-06-10 周益峰 一种三嵌段聚合物及其制备方法和应用
WO2016100086A1 (en) 2014-12-15 2016-06-23 The Johns Hopkins University Cvs transplantation for treatment of bacterial vaginosis
CN104606129B (zh) * 2015-01-21 2018-05-04 中国人民解放军广州军区武汉总医院 罗哌卡因长效注射用温敏凝胶及其制备方法
EP3250184A1 (en) * 2015-01-27 2017-12-06 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
JP6584868B2 (ja) * 2015-02-25 2019-10-02 学校法人 関西大学 ゲル素材及びその製造方法
EP3095440B1 (en) 2015-05-19 2020-01-15 PLS-Design GmbH Antigen-specific immunotherapy using tolerizing liposomes
WO2017033941A1 (ja) * 2015-08-24 2017-03-02 株式会社スリー・ディー・マトリックス 生分解性インジェクタブルゲル
CN105878174B (zh) * 2016-04-26 2021-06-29 广州帝奇医药技术有限公司 一种固体分散体及其制备方法与应用
CN106349466B (zh) * 2016-09-02 2019-09-20 广东众生药业股份有限公司 一种新的生物医用聚醚/聚酯嵌段共聚物的制备方法
EP3600437A4 (en) * 2017-03-31 2021-01-06 Rowan University OPTICALLY CLEAR IN-SITU EDUCATION OF BIODEGRADABLE NANOCARRIERS FOR EYE THERAPY AND THE SAME USING METHOD
CN110832006B (zh) * 2017-04-28 2022-10-14 赢创运营有限公司 可生物降解的骨胶
EP3723863A1 (en) 2017-10-18 2020-10-21 Luxembourg Institute of Health (LIH) Hydrogel-embedded oligodeoxynucleotides as tolerogenic adjuvant for subcutaneous immunotherapy
EP3787670A1 (en) 2017-10-18 2021-03-10 Luxembourg Institute of Health (LIH) Induction of allergen-specific tregs prior to oral or sublingual immunotherapy of food allergy
CN109498804B (zh) * 2018-12-04 2022-07-26 中国人民解放军军事科学院军事医学研究院 一种温度响应型狂犬疫苗递送系统
EP3679928A1 (fr) * 2019-01-08 2020-07-15 Atlangram Composition pharmaceutique de type gel pour traiter/prevenir une infection
CN110669184B (zh) * 2019-10-16 2022-05-31 临沂大学 一种具有药物释放功能的形状记忆高分子材料的制备方法及所得产品和应用
GB202103785D0 (en) * 2021-03-18 2021-05-05 UCB Biopharma SRL Formulations
CN114699566B (zh) * 2022-04-08 2022-12-20 海泽临床成果转化医学研究院(无锡)有限公司 一种可吸收结扎夹的制备方法
CN117547654B (zh) * 2023-12-04 2024-06-21 上海长征医院 一种仿生负载rhBMP-2骨修复材料及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3786309T2 (de) * 1986-09-05 1994-02-10 American Cyanamid Co Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme.
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
FR2741628B1 (fr) * 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
WO1999007343A1 (en) * 1997-08-08 1999-02-18 University Of Utah Research Foundation Injectable biodegradable block copolymer gels for use in drug delivery

Also Published As

Publication number Publication date
ES2239408T3 (es) 2005-09-16
IL135415A (en) 2008-04-13
AU9678098A (en) 1999-04-27
WO1999018142A1 (en) 1999-04-15
CN1195788C (zh) 2005-04-06
JP2012012606A (ja) 2012-01-19
EP1034207A1 (en) 2000-09-13
EP1034207B1 (en) 2005-03-02
AU736812B2 (en) 2001-08-02
CN1282345A (zh) 2001-01-31
IL135415A0 (en) 2001-05-20
JP2002516910A (ja) 2002-06-11
KR20010030889A (ko) 2001-04-16
CA2305621C (en) 2009-01-20
AR015175A1 (es) 2001-04-18
CA2305621A1 (en) 1999-04-15
DE69829204T2 (de) 2005-12-15
JP4656725B2 (ja) 2011-03-23
EP1034207A4 (en) 2002-04-17
JP4903256B2 (ja) 2012-03-28
JP2010144178A (ja) 2010-07-01
TR200000900T2 (tr) 2000-08-21
KR100633939B1 (ko) 2006-10-16
PT1034207E (pt) 2005-07-29
DE69829204D1 (en) 2005-04-07
BR9815239B1 (pt) 2010-07-13
KR20010030891A (ko) 2001-04-16
ATE290037T1 (de) 2005-03-15
BR9815239A (pt) 2001-12-11

Similar Documents

Publication Publication Date Title
HK1031736A1 (en) Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties.
ZA989009B (en) Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
PT1141079E (pt) Copolímeros de tribloco de poliéster, polietilenoglicol, de baixo peso molecular, biodegradáveis, com propriedades de gelificação térmica inversa
AU7520096A (en) Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers
ZA965537B (en) High strength, fast absorbing, melt processable, glycoliderich, poly(glycolide-CO-p-dioxanone) copolymers.
ZA968255B (en) High strength, melt processable, lactide-rich, poly (lactide-co-p-dioxanone) copolymers.
IS5995A (is) Þríhringja hindrar fyrir pólý (ADP-róbósa) fjölliðara
ZA978537B (en) Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
MY126458A (en) Polyesters including isosorbide as a comonomer blended with other thermoplastic polymers
JP2002525404A5 (xx)
ZA200204603B (en) Amphiphilic polymers and polypeptide conjugates comprising same.
ZA9711200B (en) Porous polyorganosiloxane polymers.
DK0792311T3 (da) Biologisk nedbrydelige polymerer, fremgangsmåde til fremstilling heraf samt anvendelse heraf til fremstilling af bionedbryd
WO2006023388A3 (en) Biodegradable diblock copolymers having reverse thermal gelation
AU8679198A (en) Modified polylactide compositions, water-responsive, biodegradable films and fibers comprising polylactide and poly(vinyl alcohol) and methods for making the same
CA2399533A1 (en) Polydimethylsiloxane and fluorosurfactant fusing release agent
ZA200001591B (en) Polymer compositions.
AU2001259395A1 (en) Hybrid end-capped reactive silicone polymers
PL343607A1 (en) Poly(alkylene arylates) having optical properties
ZA972383B (en) High temperature, low viscosity thermoplastic elastomer block copolymer compositions.
GB2353526B (en) Novel photoresist monomers,polymers thereof,and photoresist compositions containing the same
ZA200000614B (en) Olefin polymer composition having low smoke generation and fiber, film and fabric prepared therefrom.
DK1034207T3 (da) Bionedbrydelige poly(lactid-co-glycolid)-polyethylenglycol-triblok-copolymerer med lav molekylvægt med omvendte termiske geleringsegenskaber
WO2001090220A3 (en) Method for preparing and using supported phosohazenium catalysts
MXPA00000873A (es) Polimeros de condensacion modificados que contienen grupos de acetidina en conjuncion con mitades de hidrocarburo alifaticas adecuadas para la fabricacion de papel.

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20181001